股息支付 - Agilent Technologies宣布将于2024年4月24日支付每股普通股23.6美分的季度股息[1] - 未来股息的时间和金额将由Agilent的董事会确定和批准[2] 公司背景 - Agilent Technologies是一家全球领先的分析和临床实验室技术公司，提供仪器、软件、服务和专业知识，帮助客户实现卓越科学成果[3] 前瞻性声明 - 该新闻稿包含前瞻性声明，涉及公司的股息计划和未来支付义务[4]

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that Padraig McDonnell, president of the Agilent CrossLab Group (ACG), has been named CEO-elect and chief operating officer (COO) of the company, succeeding current President and CEO Mike McMullen who will retire. McDonnell will become Agilent’s president and CEO and join Agilent’s Board of Directors on May 1. After nearly 40 years with Agilent and its predecessor Hewlett-Packard Co., McMullen will continue as CEO and ...

The latest trading session saw Agilent Technologies (A) ending at $132.24, denoting a +1.91% adjustment from its last day's close. The stock exceeded the S&P 500, which registered a gain of 0.96% for the day. Meanwhile, the Dow gained 0.4%, and the Nasdaq, a tech-heavy index, added 1.3%.Shares of the scientific instrument maker have depreciated by 0.59% over the course of the past month, underperforming the Computer and Technology sector's gain of 6.92% and the S&P 500's gain of 3.69%.Analysts and investors ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the company was again named one of the Most JUST Companies in America by Just Capital and CNBC. This marks the sixth year Agilent has appeared on the exclusive list, and the fourth year the company has ranked in the top 50. The list highlights 100 companies that are performing best on business issues that matter most to the U.S. public, from paying a living wage and creating jobs to prioritizing accountability to al ...

Agilent Technologies (A) closed at $134.07 in the latest trading session, marking a +0.96% move from the prior day. The stock exceeded the S&P 500, which registered a gain of 0.06% for the day. On the other hand, the Dow registered a gain of 0.13%, and the technology-centric Nasdaq increased by 0.24%.The scientific instrument maker's stock has climbed by 1.3% in the past month, falling short of the Computer and Technology sector's gain of 12.39% and the S&P 500's gain of 6.45%.The investment community will ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) announced today that it has received two prestigious awards from SelectScience: Best New Drug Discovery & Development Product of 2023 and Drug Discovery & Development Webinar of the Year. These accolades highlight Agilent’s commitment to innovation and excellence in drug discovery and development. The Agilent xCELLigence RTCA HT-BioTek BioSpa 8 – Screening Model was voted Best New Drug Discovery & Development Product of 2023. The A ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that CFO Bob McMahon will participate in a fireside chat at the 44th Annual TD Cowen Health Care Conference in Boston, Massachusetts, on Monday, March 4, at 2:50 p.m. EST. A live audio webcast and replay of the presentation will be available on the Agilent Investor Relations website. About Agilent Technologies Agilent Technologies Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies, ...

股价表现 - Agilent Technologies (A) 最近的股价为 $132.97，较前一个交易日收盘价下跌了 -0.06% [1] - 过去一个月，科学仪器制造商的股价上涨了 1.56%，落后于计算机和科技行业的 4.83% 和标普500指数的 2.93% [2] 财务业绩 - Agilent Technologies 将于 2024年2月27日发布财务业绩，预计每股收益为 $1.21，较去年同期下降了 11.68%，预计营收为 $1.57 亿美元，较去年同期下降了 10.53% [3] - Zacks Consensus Estimates 预计全年每股收益为 $5.48，营收为 $67.4 亿美元，较去年分别增长了 +0.74% 和下降了 -1.42% [4] 估值调整 - 分析师对 Agilent Technologies 的最新估值调整反映了短期业务模式的变化，正面的估值调整反映了分析师对公司业务和盈利能力的乐观态度 [5] - 估值调整与近期股价变动直接相关，公司形成了 Zacks Rank 模型，该模型包括这些估值调整并提供一个可行的评级系统 [6] 行业比较 - Agilent Technologies 目前的前瞻市盈率为 24.3，相比行业的前瞻市盈率 24.42，显示出一定的折价 [8] - A 目前的 PEG 比率为 3.04，该比率类似于广泛使用的市盈率，但该指标还考虑了公司的预期盈利增长率，电子测试设备行业的平均 PEG 比率在昨日收盘时为 2.74 [9] 行业排名 - 电子测试设备行业属于计算机和科技行业，目前的 Zacks Industry Rank 为 21，在所有 250+ 行业中处于前 9% 的位置 [10] - 我们的研究显示，行业组的强度由 Zacks Industry Rank 衡量，该排名是根据这些组内个股的平均 Zacks Rank 计算的，我们的研究显示，排名前 50% 的行业胜过后 50% 的行业 2 倍 [11] 信息获取 - 利用 Zacks.com 来及时了解所有这些影响股价的指标，以及其他在接下来的交易日中的变化 [12]

Investors with an interest in Electronics - Testing Equipment stocks have likely encountered both Fortive (FTV) and Agilent Technologies (A) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look.There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the best returns. The Zacks Rank favors stocks with str ...

Agilent Technologies与Incyte合作 - Agilent Technologies与Incyte达成协议，合作开发伴随诊断产品，支持Incyte的血液学和肿瘤学产品[1] - Agilent和Incyte合作开发伴随诊断项目，Agilent将继续扩展其伴随诊断产品组合，Incyte将利用Agilent在IVD检测方面的专业知识支持临床试验和产品注册[2] - Agilent的伴随诊断部门副总裁Paul Beresford强调合作的重要性，希望通过伴随诊断的力量改变癌症治疗范式[3] - Incyte的转化医学集团副总裁Jeff Jackson表示对合作的期待，认为Agilent在伴随诊断开发方面的专业知识和商业记录令人印象深刻[3] 伴随诊断市场预测 - 伴随诊断市场预计到2030年将扩大至近140亿美元，用于指导越来越多癌症和其他慢性疾病的治疗决策[1] - 伴随诊断市场预计到2030年将达到137.4亿美元规模[4] Agilent的产品和合作伙伴 - Agilent在精准肿瘤领域拥有丰富的化学和技术组合，提供伴随诊断开发的产品和合作伙伴，如HercepTest和PDL-1 IHC 22C3[3]